These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30784233)

  • 21. Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis.
    Devoe DJ; Farris MS; Townes P; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):169-180. PubMed ID: 29938910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    O'Donnell CP; Allott KA; Murphy BP; Yuen HP; Proffitt TM; Papas A; Moral J; Pham T; O'Regan MK; Phassouliotis C; Simpson R; McGorry PD
    J Clin Psychiatry; 2016 Dec; 77(12):e1610-e1617. PubMed ID: 27835719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
    Breier A; Liffick E; Hummer TA; Vohs JL; Yang Z; Mehdiyoun NF; Visco AC; Metzler E; Zhang Y; Francis MM
    Schizophr Res; 2018 Sep; 199():395-402. PubMed ID: 29588126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.
    Armando M; De Crescenzo F; Vicari S; Digilio MC; Pontillo M; Papaleo F; Amminger GP
    Early Interv Psychiatry; 2016 Oct; 10(5):390-6. PubMed ID: 25345540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis.
    Dwir D; Cabungcal JH; Xin L; Giangreco B; Parietti E; Cleusix M; Jenni R; Klauser P; Conus P; Cuénod M; Steullet P; Do KQ
    Schizophr Bull; 2021 Oct; 47(6):1782-1794. PubMed ID: 34080015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VR-SOAP, a modular virtual reality treatment for improving social activities and participation of young people with psychosis: a study protocol for a single-blind multi-centre randomized controlled trial.
    Meins IA; Muijsson-Bouwman DC; Nijman SA; Greaves-Lord K; Veling W; Pijnenborg GHM; van der Stouwe ECD
    Trials; 2023 Apr; 24(1):278. PubMed ID: 37061694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.
    McGorry PD; Yung AR; Phillips LJ; Yuen HP; Francey S; Cosgrave EM; Germano D; Bravin J; McDonald T; Blair A; Adlard S; Jackson H
    Arch Gen Psychiatry; 2002 Oct; 59(10):921-8. PubMed ID: 12365879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Gee D; Crisp K; Pearce T; Newman B; Spiliotacopoulos D; Castle D; McGorry PD
    J Clin Psychiatry; 2009 Apr; 70(4):477-86. PubMed ID: 19323964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interventions in people at risk of developing first episode psychosis: a survey of current randomised controlled studies].
    Müller H; Wießmann T; Bechdolf A
    Fortschr Neurol Psychiatr; 2012 Oct; 80(10):570-9. PubMed ID: 23033203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.
    Phillips LJ; Nelson B; Yuen HP; Francey SM; Simmons M; Stanford C; Ross M; Kelly D; Baker K; Conus P; Amminger P; Trumpler F; Yun Y; Lim M; McNab C; Yung AR; McGorry PD
    Aust N Z J Psychiatry; 2009 Sep; 43(9):818-29. PubMed ID: 19670055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifamily group psychoeducation and cognitive remediation for first-episode psychosis: a randomized controlled trial.
    Breitborde NJ; Moreno FA; Mai-Dixon N; Peterson R; Durst L; Bernstein B; Byreddy S; McFarlane WR
    BMC Psychiatry; 2011 Jan; 11():9. PubMed ID: 21226941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early interventions to prevent psychosis: systematic review and meta-analysis.
    Stafford MR; Jackson H; Mayo-Wilson E; Morrison AP; Kendall T
    BMJ; 2013 Jan; 346():f185. PubMed ID: 23335473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.
    Sepehrmanesh Z; Heidary M; Akasheh N; Akbari H; Heidary M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():289-296. PubMed ID: 29126981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial.
    Berkhof M; van der Stouwe ECD; Lestestuiver B; Van't Hag E; van Grunsven R; de Jager J; Kooijmans E; Zandee CER; Staring ABP; Pot-Kolder RMCA; Vos M; Veling W
    BMC Psychiatry; 2021 Oct; 21(1):496. PubMed ID: 34635063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is clinical intervention in the ultra high risk phase effective?
    McGuire P; Selvaraj S; Howes O
    Braz J Psychiatry; 2011 Oct; 33 Suppl 2():s161-74. PubMed ID: 22286566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.